Next Article in Journal
The Advancement of In Vitro Lipolysis: Two-Step Flow-Through Method for the Evaluation of Lipid-Based Drug Delivery Systems
Next Article in Special Issue
The Impact of Substance Use Disorder and Drug Transfer into Breast Milk: Implications for Maternal and Infant Health
Previous Article in Journal
Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review
Previous Article in Special Issue
Clinical Pharmacokinetics of Fexofenadine: A Systematic Review
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(5), 544; https://doi.org/10.3390/pharmaceutics17050544
Action Date Notes Link
article html file updated 22 April 2025 16:02 CEST Original file -
article xml file uploaded 22 April 2025 16:03 CEST Original file -
article xml uploaded. 22 April 2025 16:03 CEST Update https://www.mdpi.com/1999-4923/17/5/544/xml
article pdf uploaded. 22 April 2025 16:03 CEST Version of Record https://www.mdpi.com/1999-4923/17/5/544/pdf
article supplementary file uploaded. 22 April 2025 16:03 CEST - https://www.mdpi.com/1999-4923/17/5/544#supplementary
article html file updated 25 June 2025 01:21 CEST Update https://www.mdpi.com/1999-4923/17/5/544/html
Back to TopTop